Terms ending in 2043
Every in-force patent on Sanofi's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,488,886 | Electronically-Controlled Capturing System for Drug Delivery Systems In force · High confidence | Sanofi | In force | High confidence | |
| US 12,612,360 | Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds and Their Derivatives, Processes for Their Preparation and Therapeutic Uses Thereof In force · High confidence | Sanofi | In force | High confidence | |
| US 12,582,634 | Synthetic Methods for Preparation of 4-(2-Chloro-4-Methoxy-5-Methylphenyl)-N-[(1S)-2-Cyclopropyl-1-(3-Fluoro-4-Methylphenyl)ETHYL]-5-Methyl-N-PROP-2-YNYL-1,3-Thiazol-2-Amine In force · High confidence | Sanofi | In force | High confidence | |
| US 12,545,640 | Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof In force · High confidence | Sanofi | In force | High confidence | |
| US 12,583,861 | DERIVATIVES OF IMIDAZO[4,5-d]PYRIDAZINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION In force · High confidence | Sanofi | In force | High confidence | |
| US 12,434,013 | Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,682,987 | Molecular Design Using Local Exploration Sanofi, Ecole Normale Superieure, Sorbonne Universite and Centre National de la Recherche Scientifique In force · High confidence | Sanofi, Ecole Normale Superieure, Sorbonne Universite and Centre National de la Recherche Scientifique | In force | High confidence | |
| US 12,434,006 | Assembly for a Drug Delivery Device, Drug Delivery Device and Method for Producing a Drug Delivery Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,434,007 | Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,435,378 | Pks-Island Positive E. Coli as Marker of Negative Response to ANTI-PD1 Therapy in Colorectal Cancer In force · High confidence | Sanofi | In force | High confidence | |
| 58 more term ends in 2043 · Pro | |||||
10 of 68 patents shown. Soonest term end first, then patent number.
Pro members see all 68.
65 of these are in force and held by Sanofi.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.